Abhigra
$ 69,00 – $ 173,00Price range: $ 69,00 through $ 173,00
Acamprol
$ 62,00 – $ 188,00Price range: $ 62,00 through $ 188,00
Abilify
$ 45,00 – $ 413,00Price range: $ 45,00 through $ 413,00
Abilify is an atypical antipsychotic medication designed to help balance specific natural substances in the brain. It is primarily indicated for the treatment of schizophrenia in both adults and adolescents. This medication is also highly effective in managing manic or mixed episodes associated with bipolar I disorder. Additionally, Abilify can be used as a supplemental treatment for adults with major depressive disorder when standard antidepressants require further support. The drug is also approved to treat irritability associated with autistic disorder and symptoms of Tourette’s disorder.
Active substance: Aripiprazole
SKU:
Abilify
Category: AntiDepressants
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Abilify belongs to a class of medications known as atypical antipsychotics, which function by stabilizing specific neurotransmitter systems in the brain. It is prescribed for the management of complex psychiatric conditions, including schizophrenia, bipolar I disorder, and major depressive disorder as an adjunctive treatment.
In the United States, Abilify is classified as a prescription medication (Rx only) and must be administered under the guidance and monitoring of a licensed healthcare provider. The appropriate dosage and treatment duration depend on individual clinical needs and metabolic factors.
| Property | Details |
|---|---|
| Drug name | Abilify |
| Active ingredient (INN) | Aripiprazole |
| Therapeutic class | Atypical Antipsychotic (Dopamine System Stabilizer) |
| Dosage form | Oral tablet, orally disintegrating tablet, oral solution |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) only |
| Primary purpose | Treatment of schizophrenia, bipolar I mania, adjunctive depression treatment |
Clinical Overview and Pharmacological Profile
How the drug works
Abilify contains aripiprazole, a second-generation atypical antipsychotic. The precise mechanism of action is mediated through a combination of partial agonist activity at central dopamine D2 and serotonin 5-HT1A receptors, alongside antagonist activity at serotonin 5-HT2A receptors. By acting as a dopamine system stabilizer, aripiprazole enhances dopaminergic activity in brain areas experiencing sub-optimal signaling while attenuating transmission in areas with excessive dopamine activity. This dual modulation helps normalize neurotransmitter pathways responsible for mood regulation, cognition, and perception.
Main uses
Abilify is approved by the U.S. Food and Drug Administration (FDA) for several psychiatric conditions. Primary indications include the treatment of schizophrenia in adults and adolescents aged 13 and older, as well as acute treatment of manic or mixed episodes associated with bipolar I disorder as monotherapy or adjunctive therapy in patients aged 10 and older. It is also FDA-approved as an adjunctive treatment to antidepressant medications for major depressive disorder in adults. Additionally, Abilify is indicated for irritability associated with autistic disorder in pediatric patients (ages 6 to 17) and for Tourette’s disorder in patients aged 6 to 18. Any use for off-label indications, such as generalized anxiety disorder or agitation associated with dementia, is not FDA-approved and must be evaluated cautiously by a prescriber.
How it’s absorbed and eliminated
Following oral administration, aripiprazole is well absorbed, reaching peak plasma concentrations (Cmax) within 3 to 5 hours. Absolute oral bioavailability of the tablet formulation is approximately 87%. The medication is extensively metabolized in the liver, primarily by cytochrome P450 enzymes CYP2D6 and CYP3A4, yielding its main active metabolite, dehydro-aripiprazole. Dehydro-aripiprazole exhibits affinity for D2 receptors similar to the parent drug. The mean elimination half-life of aripiprazole is approximately 75 hours, whereas in poor metabolizers of CYP2D6, the elimination half-life can extend to roughly 146 hours. Steady-state plasma concentrations are typically attained within 14 days of initiation.
Dosage and Administration Guidance
How to take it
Abilify is available in various oral dosage forms, including standard tablets, oral disintegrating tablets, and an oral solution. Standard dosing schedules depend on the condition being treated and patient age. Doses are typically administered once daily without regard to meals. Tablets should be swallowed whole with fluid and not crushed, chewed, or divided. For orally disintegrating formulations, the tablet should be placed on the tongue to dissolve and swallowed with or without liquid. Dosing adjustments are frequently necessary for patients co-administered strong CYP2D6 or CYP3A4 inhibitors or inducers. Prescribers determine individual dosage titrations based on clinical response and tolerability.
First days of treatment
When initiating Abilify, patients may notice initial changes in energy or alertness within the first few days to weeks. Early effects can include mild sedation or restlessness, while full therapeutic improvements in mood, thought processes, or behavioral symptoms often require several weeks of continuous administration. Consistent daily administration is necessary to maintain steady therapeutic drug levels. Patients should not modify their schedule or stop treatment early if immediate changes are not perceived.
If you skip a dose
If a dose of Abilify is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule resumed. Patients should never double the dose to make up for a missed administration. Maintaining a regular daily routine helps prevent fluctuations in systemic blood concentrations.
Safety Information and Interactions
Important precautions
Abilify carries two FDA boxed warnings. First, elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death; Abilify is not approved for dementia-related psychosis. Second, antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients; patients starting adjunctive therapy for depression should be monitored closely for clinical worsening. Additional precautions include neuroleptic malignant syndrome (NMS), tardive dyskinesia, metabolic changes (hyperglycemia, dyslipidemia, weight gain), orthostatic hypotension, leukopenia/neutropenia, and pathological impulse-control behaviors such as compulsive gambling or eating.
Adverse reactions
Common side effects reported in clinical trials include akathisia (an intense feeling of inner restlessness), nausea, vomiting, constipation, headache, dizziness, insomnia, and somnolence. Extrapyramidal symptoms, such as tremor or muscle stiffness, may also occur. Uncommonly, patients may experience metabolic alterations including increased blood glucose levels, weight gain, or elevated plasma lipid concentrations. Patients should report persistent or distressing adverse reactions to their prescribing physician.
Compatibility with other medicines
Aripiprazole metabolism is significantly influenced by drugs affecting hepatic enzymes. Co-administration with strong CYP3A4 inhibitors (such as ketoconazole or itraconazole) or strong CYP2D6 inhibitors (such as fluoxetine or paroxetine) increases aripiprazole exposure, requiring a dose reduction (typically by half). Conversely, strong CYP3A4 inducers (such as carbamazepine or rifampin) enhance aripiprazole clearance, necessitating an increase in the prescribed dose. Concomitant use with antihypertensive agents may enhance hypotensive effects due to alpha-1 adrenergic receptor antagonism. Central nervous system depressants, including benzodiazepines, may intensify sedation.
Food and alcohol
Abilify can be taken with or without food, as food intake does not significantly affect the overall bioavailability or peak concentration of aripiprazole. However, alcohol consumption should be avoided during treatment. Ethanol can exacerbate central nervous system depression, leading to increased drowsiness, impaired motor coordination, and altered judgment. Patients should exercise caution and discuss dietary or lifestyle habits with their prescribing physician.
Storage and expiration
Abilify tablets and oral solutions should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Protect the medication from excess moisture and heat. Oral solution bottles must be used within 6 months after opening, or before the manufacturer expiration date, whichever comes first. Keep all formulations securely out of reach of children and pets.
Q&A
What should be done if akathisia or severe restlessness develops after starting Abilify?
Akathisia is a recognized side effect of aripiprazole characterized by an intense urge to move. If restlessness or difficulty sitting still occurs, contact the prescribing doctor promptly. The physician may adjust the dosage or prescribe an adjunctive medication to manage these symptoms rather than stopping therapy abruptly.
How long does it take for Abilify to clear from the body after stopping?
Given the mean elimination half-life of aripiprazole (approximately 75 hours) and its active metabolite dehydro-aripiprazole (approximately 94 hours), it takes roughly 2 to 3 weeks for the drug to be largely cleared from systemic circulation after discontinuation.
Can Abilify be taken safely during pregnancy?
Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery. Abilify should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as determined by a healthcare provider.
Is routine blood monitoring necessary while taking Abilify?
Healthcare providers frequently order periodic blood tests to evaluate complete blood counts (CBC), fasting plasma glucose, and lipid profiles. Monitoring helps detect potential metabolic changes, neutropenia, or hyperglycemia early during treatment.
Does Abilify affect a patient’s ability to drive or operate machinery?
Because Abilify can cause somnolence, dizziness, and impaired motor skills, patients should avoid operating hazardous machinery or driving motor vehicles until they are reasonably certain that the medication does not adversely affect their alertness and coordination.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
5 mg ,10mg ,15mg ,20mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Anafranil
$ 41,00 – $ 457,00Price range: $ 41,00 through $ 457,00
Active substance: Clomipramine
More Details
This product has multiple variants. The options may be chosen on the product page
Celexa
$ 7,00 – $ 193,00Price range: $ 7,00 through $ 193,00
Active substance: Citalopram
More Details
This product has multiple variants. The options may be chosen on the product page
Daxid
$ 42,00 – $ 229,00Price range: $ 42,00 through $ 229,00
Active substance: Sertraline
More Details
This product has multiple variants. The options may be chosen on the product page
Elavil
$ 39,00 – $ 222,00Price range: $ 39,00 through $ 222,00
Active substance: amitriptyline
More Details
This product has multiple variants. The options may be chosen on the product page
Endep
$ 22,00 – $ 398,00Price range: $ 22,00 through $ 398,00
Active substance: amitriptyline
More Details
This product has multiple variants. The options may be chosen on the product page
Lexapro
$ 40,00 – $ 265,00Price range: $ 40,00 through $ 265,00
Active substance: Escitalopram
More Details
This product has multiple variants. The options may be chosen on the product page
Lithium
$ 16,00 – $ 139,00Price range: $ 16,00 through $ 139,00
Active substance: Lithium
More Details
This product has multiple variants. The options may be chosen on the product page
Pexep
$ 42,00 – $ 162,00Price range: $ 42,00 through $ 162,00
Active substance: paroxetine
More Details
This product has multiple variants. The options may be chosen on the product page
